Хайлтын үр дүнгүүд - Huang, Funan
- 5-н 1 - 5 үр дүнгүүдийг харуулж байна
-
1
No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects -н Huang, Funan, Ajavon, Antoinette, Huang, Erya, Lettieri, John, Liu, Rong, Peña, Carol, Berse, Matthias
Хэвлэсэн 2017текст -
2
Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment -н Zurth, Christian, Nykänen, Pirjo, Wilkinson, Gary, Taavitsainen, Päivi, Vuorela, Annamari, Huang, Funan, Reschke, Susanne, Koskinen, Mikko
Хэвлэсэн 2021текст -
3
A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors -н Weekes, Colin, Lockhart, A. Craig, Lee, James J., Sturm, Isrid, Cleton, Adriaan, Huang, Funan, Lenz, Heinz‐Josef
Хэвлэсэн 2019текст -
4
Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer -н Grevel, Joachim, Jentsch, Garrit, Austin, Rupert, Prins, Nicolaas H., Lettieri, John, Mitchell, David, Huang, Funan, Brose, Marcia S., Schlumberger, Martin, Meinhardt, Gerold, Peña, Carol E. A., Ploeger, Bart A.
Хэвлэсэн 2019текст -
5
Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer -н Wong, Selina K., Chu, Quincy S.C., Spratlin, Jennifer L., Sangha, Randeep, McEwan, Alexander J.B., Morrish, Donald W., Arndt, Diane, Sergenson, Gwen, Cleton, Adriaan, Huang, Funan, Sawyer, Michael B.
Хэвлэсэн 2019текст